Blocking 17 beta-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach

Gonda F. J. Konings, Karlijn M. C. Cornel, Sofia Xanthoulea, Bert Delvoux, Margaretha A. Skowron, Loes Kooreman, Pasi Koskimies, Camilla Krakstad, Helga B. Salvesen, Kim van Kuijk, Yannick J. M. Schrooders, Marc Vooijs, Arjan J. Groot, Marlies Y. Bongers, Roy F. P. M. Kruitwagen, Andrea Romano,

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)203-214
Number of pages12
JournalJournal of Pathology
Volume244
Issue number2
DOIs
Publication statusPublished - 1 Feb 2018

Keywords

  • 17 beta-hydroxysteroid dehydrogenase type 1
  • endometrial cancer
  • estrone
  • 17 beta-estradiol
  • estrogen metabolism
  • STEROID SULFATASE
  • CHORIOALLANTOIC MEMBRANE
  • ESTROGEN BIOSYNTHESIS
  • PHASE-II
  • IN-VIVO
  • CARCINOMA
  • INHIBITORS
  • EXPRESSION
  • 17-BETA-ESTRADIOL
  • METABOLISM

Cite this